Akebia - International Biopharmaceutical Industry

Current Edition

news

Akebia to lay off 42% of workforce, suspend trials after FDA drug rejection

Dive Brief: Akebia Therapeutics will lay off 42% of its workforce after the Food and Drug Administration last month rejected its most advanced experimental drug, a...

11 April 2022 news Akebia | Drug

Continue Reading →

news

FDA rejects Akebia drug, dealing another blow to anemia pills

Dive Brief: The Food and Drug Administration rejected an Akebia Therapeutics' anemia pill vadadustat, the company announced Wednesday, over concerns the drug isn't...

1 April 2022 news Akebia | anemia

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Akebia to lay off 42% of workforce, suspend trials after FDA drug rejection

FDA rejects Akebia drug, dealing another blow to anemia pills

International Biopharmaceutical Industry